Cargando…

A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions

BACKGROUNDS AND OBJECTIVES: Drug-coated balloons (DCBs) have shown promising benefits in improving the outcomes for patients with peripheral artery disease. Several randomized clinical trials have reported that paclitaxel-coated balloon significantly reduce the rates of restenosis and the need for r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Leng, Ye, Wei, Zhang, Lan, Jin, Xing, Shu, Chang, Jiang, Jin-song, Yang, Mu, Wu, Dan-ming, Li, Ming, Yu, Guan-feng, Yang, Jun, Huang, Jian-hua, Wang, Xiao-bai, Li, Xiao-qiang, Jiang, Wei-liang, Wu, Zhi-qun, Liu, Chang-wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982076/ https://www.ncbi.nlm.nih.gov/pubmed/35391838 http://dx.doi.org/10.3389/fcvm.2022.821672

Ejemplares similares

Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics
por: Du, Xin, et al.
Publicado: (2019)

Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
por: Wang, Zhihong, et al.
Publicado: (2022)

Twelve-Month Results From the First-in-China Prospective, Multi-Center, Randomized, Controlled Study of the FREEWAY Paclitaxel-Coated Balloon for Femoropopliteal Treatment
por: Zhang, Bihui, et al.
Publicado: (2021)

Impact of plaque and luminal morphology in balloon angioplasty of the femoropopliteal artery: an intravascular ultrasound analysis
por: Zou, Yuchi, et al.
Publicado: (2023)

Feasibility and Clinical Outcomes of Peripheral Drug-Coated Balloon in High-Risk Patients with Femoropopliteal Disease
por: Jang, Shih-Jung, et al.
Publicado: (2015)

Five-Year Outcomes of Post-Drug-Coated Balloon Angioplasty Dissection in Complex Femoropopliteal Artery Disease
por: Ren, Hao, et al.
Publicado: (2021)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Clinical Outcomes of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon Alone in the Treatment of Femoropopliteal Artery Disease
por: Cha, Jung-Joon, et al.
Publicado: (2021)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

The factors influencing the efficiency of drug-coated balloons
por: Cao, Zheng, et al.
Publicado: (2022)

Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
por: Zhen, Yanhua, et al.
Publicado: (2020)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
por: Li, Liqiang, et al.
Publicado: (2022)

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis
por: Cao, Shaobo, et al.
Publicado: (2021)

One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
por: Yu, Xiaoxi, et al.
Publicado: (2021)

Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
por: Shirai, Shigemitsu, et al.
Publicado: (2022)

Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
por: Hayakawa, Naoki, et al.
Publicado: (2022)

Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases
por: Lang, Xinyue, et al.
Publicado: (2022)

Efficacy of Super Slow Inflation as Lesion Preparation for Drug-Coated Balloons in Femoropopliteal Lesions
por: Sugihara, Makoto, et al.
Publicado: (2020)

Improving the Outcomes of Complex Lesions of the Femoropopliteal Artery Using Atherectomy and Drug Coated Balloon
por: Kim, Sangmin
Publicado: (2022)

Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Femoropopliteal Arterial Disease
por: Stavroulakis, Konstantinos, et al.
Publicado: (2022)

A prospective, multicenter, real-world observational study evaluating the impact of tibial runoff on clinical outcomes after endovascular therapy for femoropopliteal lesions: Research protocol
por: Liu, Yang, et al.
Publicado: (2022)

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Tong, Zhu, et al.
Publicado: (2020)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Case Report: Combination of Pressure Guidewire and Optical Coherence Tomography-Guided Drug-Coated Balloon Revascularization for Renal Artery Fibromuscular Dysplasia
por: Li, Yuxi, et al.
Publicado: (2022)

One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial
por: Lai, Zhichao, et al.
Publicado: (2020)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Efficacy and safety of drug-coated balloon combined with cutting balloon for side branch of true coronary bifurcation lesions: Study protocol for a multicenter, prospective, randomized controlled trial
por: Wu, Haoyu, et al.
Publicado: (2022)

Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of chronic obstructive femoropopliteal arterial disease
por: Liu, Hui, et al.
Publicado: (2020)

Protocol of the evolution study: A prospective, multicenter, observational study evaluating the effect and health economics of endovascular treatment in patients with moderate and severe calcification of femoropopliteal artery
por: Pan, Jun, et al.
Publicado: (2022)

Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon
por: Zhang, Yuxuan, et al.
Publicado: (2021)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
por: Hanna, Jonathan, et al.
Publicado: (2023)

Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in de novo Lesions of Large Coronary Arteries
por: Hu, Feng-Wang, et al.
Publicado: (2022)

Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions
por: Haraguchi, Takuya, et al.
Publicado: (2023)

Long-term outcomes of drug-coated balloon treatment of calcified coronary artery lesions: a multicenter, retrospective, propensity matching study
por: Shan, Yingguang, et al.
Publicado: (2023)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

Multiple drug-coated balloons can be used effectively for peripheral arterial disease including long femoropopliteal lesions
por: Chu, Wongong, et al.
Publicado: (2021)

First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease
por: Mwipatayi, Bibombe Patrice, et al.
Publicado: (2017)

BioMimics 3D Stent in Femoropopliteal Lesions: 3-Year Outcomes with Propensity Matching for Drug-Coated Balloons
por: Piorkowski, Michael, et al.
Publicado: (2023)

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
por: Schroë, Herman, et al.
Publicado: (2017)

Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
por: Park, Jong-Il, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i1a5ni9ausj3ba33tulcvcarrp